Found: 3 articles
Article | Edition |
---|---|
Salukhov V.V., Shustov S.B., Petrankov K.V.
Advantages of combined use of sodium-glucose co-transporter type 2 inhibitors and glucagon-like peptide-1 receptor agonists relatively to cardiovascular and renal outcomes in patients with type 2 diabetes mellitus
|
№8 / 2024 |
Shchemeleva E.V., Skorodumova E.A.
Febuxostat: Efficacy and safety of the drug, prospects for application (literature review)
|
№5 / 2024 |
Sycheva A.S., Malyavina M.A., Tebueva L.V., Grigorievsky E.D., Kebina A.L., Vertkin A.L., Solodov A.A., Semenyakin I.V., Levchenko O.V., Yanushevich O.O.
Peculiarities of COVID-19 coronavirus infection course in patients with comorbid pathology
|
№6 / 2022 |